Fascinating update on the diagnostic and staging criteria! Considering these changes, I wonder if you've looked into Actinogen Medical's work with Xanamem, which targets cortisol-related cognitive decline in Alzheimer's. Their approach could add an interesting layer to your discussions. Maybe worth exploring in a future video?
Fascinating update on the diagnostic and staging criteria! Considering these changes, I wonder if you've looked into Actinogen Medical's work with Xanamem, which targets cortisol-related cognitive decline in Alzheimer's. Their approach could add an interesting layer to your discussions. Maybe worth exploring in a future video?